Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000412399 | SCV000254556 | likely benign | Peutz-Jeghers syndrome | 2023-12-24 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000412399 | SCV000487811 | uncertain significance | Peutz-Jeghers syndrome | 2015-11-18 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000579483 | SCV000686684 | likely benign | Hereditary cancer-predisposing syndrome | 2016-07-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000579483 | SCV001188675 | benign | Hereditary cancer-predisposing syndrome | 2022-07-20 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001706620 | SCV001907131 | likely benign | not provided | 2018-06-26 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000412399 | SCV002057279 | uncertain significance | Peutz-Jeghers syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000579483 | SCV002526930 | likely benign | Hereditary cancer-predisposing syndrome | 2021-11-27 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV000412399 | SCV004017941 | likely benign | Peutz-Jeghers syndrome | 2023-04-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |